On March 4, 2024, Director Thomas Avery executed a sale of 1,000 shares of CRA International Inc (CRAI, Financial), according to a recent SEC filing. The transaction was carried out at a price of $138.05 per share.
CRA International Inc is a global consulting firm that offers economic, financial, and management consulting services. The company provides its services to major industries, including technology, banking, energy, and healthcare, among others. CRA International Inc assists clients in evaluating complex economic and financial matters such as antitrust, mergers and acquisitions, securities litigation, and forensic accounting.
Over the past year, Thomas Avery has sold a total of 1,000 shares of CRA International Inc and has not made any purchases of the stock. The insider's recent sale contributes to a pattern observed over the last year, where there have been no insider buys and a total of 9 insider sells for the company.
The stock market cap of CRA International Inc stands at $970.998 million, with the shares trading at $138.05 on the day of the insider's transaction.
The price-earnings ratio of CRA International Inc is currently 25.62. This valuation is above the industry median of 17.79 and also exceeds the historical median price-earnings ratio of the company.
Based on the current share price and the GuruFocus Value of $109.80, CRA International Inc has a price-to-GF-Value ratio of 1.26, indicating that the stock is considered Modestly Overvalued in relation to its GF Value.
The GF Value is calculated by GuruFocus and takes into account historical trading multiples, an adjustment factor based on the company's past performance, and future business performance estimates provided by Morningstar analysts.
The insider trend image above reflects the recent insider selling activity for CRA International Inc.
The GF Value image above provides a visual representation of CRA International Inc's current valuation in comparison to its intrinsic value estimate according to GuruFocus.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
